6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1h ago	Buffalo Potash Files Annual Information Form and New Technical Report
2h ago	Ionik Announces 30-Day Extension of Senior Debt Facility
3h ago	Galiano Gold Announces Revisions to Omnibus Equity Incentive Plan
3h ago	Yatra Online, Inc. Announces Results for the Three Months and Year Ended March 31, 2026
3h ago	UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change

About

1,399.20INR-2.70 -0.19%

Live at 05:16 GMT+00:00

Market Cap$11.77B

P/E Ratio29.15

Volume917.3K

Beta0.43

RSI61.92

Gross Margin42.74%

Health TechnologyPharmaceuticals: Other

Cipla Ltd — investor relations, events, news, and company updates on 6ix.

Latest News

Press Release May 13 2026

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis

Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy

Community Chat

Ask AI